MarketBeat Instant News Alerts 2 hours agoResearch Analysts Set Expectations for KNSA Q2 EarningsMarketBeatKiniksa Pharmaceuticals, Ltd. (NASDAQ:KNSA - Free Report) - Stock analysts at Wedbush decreased their Q2 2025 EPS estimates for shares of Kiniksa Pharmaceuticals in a report released on Tuesday, April 29th. Wedbush analyst D. Nierengarten now anticipates that the company will earn $0.24 per shareNASDAQ:KNSARead Research Analysts Set Expectations for KNSA Q2 Earnings2 hours agoWedbush Has Pessimistic Outlook of LGI Homes Q2 EarningsMarketBeatLGI Homes, Inc. (NASDAQ:LGIH - Free Report) - Wedbush reduced their Q2 2025 earnings per share (EPS) estimates for shares of LGI Homes in a research note issued on Tuesday, April 29th. Wedbush analyst J. Mccanless now anticipates that the financial services provider will earn $1.26 per share for NASDAQ:LGIHRead Wedbush Has Pessimistic Outlook of LGI Homes Q2 Earnings2 hours agoLeerink Partnrs Has Positive Outlook of LH Q2 EarningsMarketBeatLaboratory Co. of America Holdings (NYSE:LH - Free Report) - Equities researchers at Leerink Partnrs upped their Q2 2025 EPS estimates for Laboratory Co. of America in a research report issued on Tuesday, April 29th. Leerink Partnrs analyst M. Cherny now anticipates that the medical research compNYSE:LHRead Leerink Partnrs Has Positive Outlook of LH Q2 Earnings2 hours agoWhat is DA Davidson's Estimate for MDLZ Q2 Earnings?MarketBeatMondelez International, Inc. (NASDAQ:MDLZ - Free Report) - DA Davidson issued their Q2 2025 earnings per share (EPS) estimates for Mondelez International in a research report issued on Thursday, May 1st. DA Davidson analyst B. Holland expects that the company will earn $0.64 per share for the quaNASDAQ:MDLZRead What is DA Davidson's Estimate for MDLZ Q2 Earnings?2 hours agoQ2 EPS Estimates for Markel Group Raised by Zacks ResearchMarketBeatMarkel Group Inc. (NYSE:MKL - Free Report) - Stock analysts at Zacks Research increased their Q2 2025 earnings per share (EPS) estimates for shares of Markel Group in a research report issued on Tuesday, April 29th. Zacks Research analyst R. Department now expects that the insurance provider willNYSE:MKLRead Q2 EPS Estimates for Markel Group Raised by Zacks Research2 hours agoZacks Research Issues Optimistic Estimate for MMC EarningsMarketBeatMarsh & McLennan Companies, Inc. (NYSE:MMC - Free Report) - Zacks Research increased their Q2 2025 earnings per share estimates for Marsh & McLennan Companies in a report released on Thursday, May 1st. Zacks Research analyst R. Department now forecasts that the financial services provider will poNYSE:MMCRead Zacks Research Issues Optimistic Estimate for MMC Earnings Trending News1Rivian Automotive (RIVN) Expected to Announce Earnings on Tuesday2325,973,411 Shares in Aurora Innovation, Inc. (NASDAQ:AUR) Bought by Uber Technologies Inc3Wells Fargo & Company MN Grows Stock Holdings in Applied Digital Co. (NASDAQ:APLD)4SoundHound AI (SOUN) to Release Quarterly Earnings on Thursday5Uber Technologies Inc Makes New $71.53 Million Investment in Serve Robotics Inc. (NASDAQ:SERV)6Energy Transfer (ET) Projected to Post Quarterly Earnings on Tuesday7Randolph Co Inc Has $27.35 Million Stake in Molson Coors Beverage (NYSE:TAP)8Enbridge (NYSE:ENB) Trading 0.3% Higher After Dividend Announcement All MarketBeat Instant News Alerts Latest News Trending News Sort By Last 24 Hours Last 3 Days Last 7 Days Last 14 Days Last 30 Days Last 90 Days All Time Time Frame All Alerts Analyst Congressional Trades Consensus Corporate Buyback Dividend Earnings Earnings Preview Estimates Guidance Insider Trade Lockup Expiration Options Price SEC Filing Stock List Stock Split Alert Type Keywords 2 hours agoWhat is B. Riley's Forecast for MSA Safety Q2 Earnings?MarketBeatNYSE:MSARead What is B. Riley's Forecast for MSA Safety Q2 Earnings?2 hours agoZacks Research Issues Pessimistic Forecast for PBYI EarningsMarketBeatNASDAQ:PBYIRead Zacks Research Issues Pessimistic Forecast for PBYI Earnings2 hours agoNorthland Capmk Has Positive Outlook for RBBN Q2 EarningsMarketBeatNASDAQ:RBBNRead Northland Capmk Has Positive Outlook for RBBN Q2 Earnings2 hours agoQ2 Earnings Estimate for Repligen Issued By Leerink PartnrsMarketBeatNASDAQ:RGENRead Q2 Earnings Estimate for Repligen Issued By Leerink Partnrs2 hours agoB. Riley Analysts Increase Earnings Estimates for RogersMarketBeatNYSE:ROGRead B. Riley Analysts Increase Earnings Estimates for Rogers2 hours agoHC Wainwright Issues Optimistic Estimate for SAGE EarningsMarketBeatNASDAQ:SAGERead HC Wainwright Issues Optimistic Estimate for SAGE Earnings2 hours agoWedbush Equities Analysts Raise Earnings Estimates for SAGEMarketBeatNASDAQ:SAGERead Wedbush Equities Analysts Raise Earnings Estimates for SAGE2 hours agoWedbush Issues Negative Outlook for SIMO EarningsMarketBeatNASDAQ:SIMORead Wedbush Issues Negative Outlook for SIMO Earnings2 hours ago5AM Venture Management LLC Takes Position in Protara Therapeutics, Inc. (NASDAQ:TARA)MarketBeatNASDAQ:TARARead 5AM Venture Management LLC Takes Position in Protara Therapeutics, Inc. (NASDAQ:TARA)2 hours ago165,000 Shares in Akero Therapeutics, Inc. (NASDAQ:AKRO) Acquired by 5AM Venture Management LLCMarketBeatNASDAQ:AKRORead 165,000 Shares in Akero Therapeutics, Inc. (NASDAQ:AKRO) Acquired by 5AM Venture Management LLC2 hours ago5AM Venture Management LLC Has $7.63 Million Stock Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)MarketBeatNASDAQ:VKTXRead 5AM Venture Management LLC Has $7.63 Million Stock Position in Viking Therapeutics, Inc. (NASDAQ:VKTX)2 hours ago5AM Venture Management LLC Lowers Stock Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX)MarketBeatNASDAQ:PRAXRead 5AM Venture Management LLC Lowers Stock Holdings in Praxis Precision Medicines, Inc. (NASDAQ:PRAX)2 hours ago5AM Venture Management LLC Cuts Stock Position in Centessa Pharmaceuticals plc (NASDAQ:CNTA)MarketBeatNASDAQ:CNTARead 5AM Venture Management LLC Cuts Stock Position in Centessa Pharmaceuticals plc (NASDAQ:CNTA)2 hours agoDianthus Therapeutics, Inc. (NASDAQ:DNTH) is 5AM Venture Management LLC's 6th Largest PositionMarketBeatNASDAQ:DNTHRead Dianthus Therapeutics, Inc. (NASDAQ:DNTH) is 5AM Venture Management LLC's 6th Largest Position2 hours ago740,000 Shares in Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Acquired by Acuta Capital Partners LLCMarketBeatNASDAQ:SGMORead 740,000 Shares in Sangamo Therapeutics, Inc. (NASDAQ:SGMO) Acquired by Acuta Capital Partners LLC2 hours ago217,265 Shares in Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Purchased by 683 Capital Management LLCMarketBeatNASDAQ:ACRSRead 217,265 Shares in Aclaris Therapeutics, Inc. (NASDAQ:ACRS) Purchased by 683 Capital Management LLC2 hours ago683 Capital Management LLC Takes $577,000 Position in Inseego Corp. (NASDAQ:INSG)MarketBeatNASDAQ:INSGRead 683 Capital Management LLC Takes $577,000 Position in Inseego Corp. (NASDAQ:INSG)2 hours ago683 Capital Management LLC Purchases Shares of 57,759 Idaho Strategic Resources, Inc. (NYSEAMERICAN:IDR)MarketBeatNYSEAMERICAN:IDRRead 683 Capital Management LLC Purchases Shares of 57,759 Idaho Strategic Resources, Inc. (NYSEAMERICAN:IDR)2 hours ago683 Capital Management LLC Purchases Shares of 12,365 M-tron Industries, Inc. (NYSEAMERICAN:MPTI)MarketBeatNYSEAMERICAN:MPTIRead 683 Capital Management LLC Purchases Shares of 12,365 M-tron Industries, Inc. (NYSEAMERICAN:MPTI)2 hours ago138,263 Shares in Sagimet Biosciences Inc. (NASDAQ:SGMT) Bought by 683 Capital Management LLCMarketBeatNASDAQ:SGMTRead 138,263 Shares in Sagimet Biosciences Inc. (NASDAQ:SGMT) Bought by 683 Capital Management LLC2 hours ago683 Capital Management LLC Acquires New Holdings in FreightCar America, Inc. (NASDAQ:RAIL)MarketBeatNASDAQ:RAILRead 683 Capital Management LLC Acquires New Holdings in FreightCar America, Inc. (NASDAQ:RAIL)2 hours ago74,307 Shares in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Acquired by Acuta Capital Partners LLCMarketBeatNASDAQ:CRVSRead 74,307 Shares in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Acquired by Acuta Capital Partners LLC2 hours ago683 Capital Management LLC Takes Position in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN)MarketBeatNASDAQ:ELDNRead 683 Capital Management LLC Takes Position in Eledon Pharmaceuticals, Inc. (NASDAQ:ELDN)2 hours ago683 Capital Management LLC Invests $638,000 in Blue Ridge Bankshares, Inc. (NASDAQ:BRBS)MarketBeatNASDAQ:BRBSRead 683 Capital Management LLC Invests $638,000 in Blue Ridge Bankshares, Inc. (NASDAQ:BRBS) Featured Articles and OffersWhy D-Wave's Project With Davidson Is a Game-Changer For QuantumBy Nathan Reiff | April 30, 2025View Why D-Wave's Project With Davidson Is a Game-Changer For QuantumThe world’s first multi- trillion-dollar robotics industry …From Weiss Ratings(Ad)View The world’s first multi- trillion-dollar robotics industry …Broadcom's VMware Deal Lifts AVGO Despite Complaints By Leo Miller | April 28, 2025View Broadcom's VMware Deal Lifts AVGO Despite Complaints Joby Aviation Shares Eye Breakout After Transition Flight WinBy Jeffrey Neal Johnson | April 30, 2025View Joby Aviation Shares Eye Breakout After Transition Flight WinRivian Automotive (RIVN) Expected to Announce Earnings on TuesdayBy MarketBeat | May 3, 2025View Rivian Automotive (RIVN) Expected to Announce Earnings on TuesdayBlackrock’s Sending THIS Crypto Higher on PurposeFrom Crypto 101 Media(Ad)View Blackrock’s Sending THIS Crypto Higher on PurposeThese 3 Cybersecurity Stocks Are Defying the DownturnBy Ryan Hasson | April 29, 2025View These 3 Cybersecurity Stocks Are Defying the DownturnPalantir Earnings: 1 Bullish Signal and 1 Area of ConcernBy Chris Markoch | May 2, 2025View Palantir Earnings: 1 Bullish Signal and 1 Area of Concern Sector NewsAerospace NewsArtificial Intelligence NewsAutomotive NewsConsumer Product NewsEnergy NewsFinancial Services NewsHealthcare NewsIndustrial NewsMedia NewsManufacturing NewsTechnology NewsTransportation NewsRetail News Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
